Max Healthcare Institute recommended at ₹1,037 with accumulation at ₹1,010 and stop-loss at ₹960
Benchmark indices Sensex and Nifty closed lower on 15th September 2026 after a volatile session marked by early losses and partial recovery. The Sensex ended at 74,781.76, down 120.83 points or 0.16%, while the Nifty settled at 23,398.10, down 79.70 points or 0.34%. Foreign investors withdrew ₹13,138 crore from Indian equities in the first half of September due to global uncertainty, rising crude oil prices, and stronger US bond yields.
Retail inflation rose to 4.82% in August 2026 from 4.45% in July, marking an eight-month high and the third consecutive month above the RBI’s 4% medium-term target. Food inflation, driven by sugar, onions, ginger, and garlic, increased to 5.95%, reinforcing expectations of a possible rate hike in the October MPC meeting. Wholesale inflation stood at 9.9% in August, up from 9.8% in July.
Among key stocks to watch, Max Healthcare Institute was highlighted with a recommendation to buy at ₹1,037. Traders were advised to consider accumulating the stock if it dips to ₹1,010, with an initial stop-loss placed at ₹960 to manage downside risk. The suggestion appeared in the context of broader market movements and sector-specific developments.
Other notable market updates included gold prices declining amid inflation concerns, natural gas futures showing volatility with support at ₹265/mmBtu, and several IPOs open for subscription aiming to raise ₹24,328 crore. Power demand in August surged due to El Niño conditions, with solar generation rising 34% year-on-year.
The article also noted Kalyan Jewellers’ aggressive expansion via a franchise-owned, company-operated model, citing strong revenue growth and valuation upside, though this was presented as separate analysis and not tied to the Max Healthcare recommendation.
Market Spider rewrites market reports for information only—not investment advice. Trading in securities involves risk of loss.